SCHEMBL24112381

SCHEMBL24112381

CNC(=O)C(C)N1CCC(c2ccccc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.50
▸ RAB9A P51151 7/20 0.50
▸ SMN1; SMN2 Q16637 5/20 0.50
▸ TP53 P04637 5/20 0.50
▸ KCNH2 Q12809 1/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.49
▸ MAPT P10636 4/20 0.45
▸ NFKB1 P19838 2/20 0.45
▸ NFKB2 Q00653 2/20 0.45
▸ RELA Q04206 2/20 0.45
▸ HTT P42858 1/20 0.45
▸ STAT1 P42224 1/20 0.45
▸ LMNA P02545 3/20 0.45
▸ TSHR P16473 1/20 0.45
▸ SCD O00767 1/20 0.45
▸ SCD5 Q86SK9 1/20 0.45
▸ KDM1A O60341 1/20 0.45
▸ OPRM1 P35372 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24450335 0.88 RAB9A (0.49) NPC1RAB9ASMN1; SMN2TP53KCNH2
SCHEMBL24112355 0.86 NPC1 (0.48) NPC1RAB9ASMN1; SMN2TP53KCNH2
SCHEMBL24029313 0.85 OPRM1 (0.47) NPC1RAB9ASMN1; SMN2TP53KCNH2
SCHEMBL24450336 0.77 NPC1 (0.47) NPC1RAB9ASMN1; SMN2TP53KCNH2
SCHEMBL2603285 0.77 HRH3 (0.56) KCNH2HRH3KDM1AOPRM1
SCHEMBL12609029 0.77 HRH3 (0.56) KCNH2HRH3KDM1AOPRM1
SCHEMBL12609017 0.77 HRH3 (0.56) KCNH2HRH3KDM1AOPRM1
SCHEMBL25760663 0.77 NPC1 (0.43) NPC1RAB9ASMN1; SMN2TP53KCNH2
SCHEMBL27498941 0.76 KCNH2 (0.60) KCNH2HRH3KDM1AOPRM1PRCP
SCHEMBL26238906 0.76 KCNH2 (0.50) SMN1; SMN2KCNH2HRH3KDM1AOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021252644-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2021-12-16 — — WO disclosed
Send feedback